Halozyme Therapeutics
HALO
#2100
Rank
โ‚น654.64 B
Marketcap
โ‚น5,145
Share price
2.23%
Change (1 day)
65.83%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น140.52 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are โ‚น140.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น137.31 B-0.74%
2022-12-31โ‚น138.33 B104.8%
2021-12-31โ‚น67.54 B115.35%
2020-12-31โ‚น31.36 B-7.23%
2019-12-31โ‚น33.80 B152.68%
2018-12-31โ‚น13.38 B-32.74%
2017-12-31โ‚น19.89 B-0.42%
2016-12-31โ‚น19.97 B116.61%
2015-12-31โ‚น9.22 B16.77%
2014-12-31โ‚น7.89 B4.98%
2013-12-31โ‚น7.52 B60.02%
2012-12-31โ‚น4.70 B62.02%
2011-12-31โ‚น2.90 B-8.78%
2010-12-31โ‚น3.18 B-2.4%
2009-12-31โ‚น3.25 B10.84%
2008-12-31โ‚น2.94 B63.99%
2007-12-31โ‚น1.79 B75.96%
2006-12-31โ‚น1.01 B883.21%
2005-12-31โ‚น0.10 B51.53%
2004-12-31โ‚น68.4 M449.42%
2003-12-31โ‚น12.44 M-57.45%
2002-12-31โ‚น29.25 M18336.74%
2001-12-31โ‚น0.15 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น56.50 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.171 T 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.569 T 1,017.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.709 T 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.133 T 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น9.123 T 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA